Malin Corp. PLC | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
22,900.00
42,100.00
41,900.00
38,000
Cost of Goods Sold (COGS) incl. D&A
-
20,300.00
32,200.00
30,800.00
33,900
Gross Income
-
2,600.00
9,900.00
11,100.00
4,100
SG&A Expense
-
46,400.00
56,400.00
55,900.00
26,600
EBIT
-
43,800.00
46,500.00
44,800.00
22,500
Unusual Expense
-
400.00
11,000.00
28,700.00
18,600
Non Operating Income/Expense
-
300.00
900.00
6,400.00
8,200
Interest Expense
-
800.00
2,000.00
3,000.00
2,900
Pretax Income
-
43,900.00
59,900.00
82,400.00
35,800
Income Tax
-
200.00
300.00
1,200.00
900
Equity in Affiliates
-
5,900.00
26,400.00
25,000.00
14,900
Consolidated Net Income
-
49,600.00
86,600.00
106,200.00
49,800
Net Income
-
44,900.00
83,500.00
98,800.00
46,300
Net Income After Extraordinaries
-
44,900.00
83,500.00
98,800.00
46,300
Net Income Available to Common
-
44,900.00
83,500.00
98,800.00
46,300
EPS (Basic)
-
1.63
2.12
2.36
1.01
Basic Shares Outstanding
-
27,480.60
39,400.00
41,800.00
45,700
EPS (Diluted)
-
1.63
2.12
2.36
1.01
Diluted Shares Outstanding
-
27,480.60
39,400.00
41,800.00
45,700
EBITDA
-
41,200.00
41,500.00
39,400.00
17,300
Non-Operating Interest Income
-
-
500.00
500.00
-
Minority Interest Expense
-
4,700.00
3,100.00
7,400.00
3,500

About Malin Corp.

View Profile
Address
2 Harbour Square
Dublin Dublin
Ireland
Employees -
Website http://www.malinplc.com
Updated 07/08/2019
Malin Corp. Plc. is a life sciences company. It acquires majority or significant minority equity positions in private, pre-Initial Public Offering, and pre-trade operating businesses in the life sciences industry particularly therapeutics, devices, and diagnostic companies.